BMRN vs FUNC · P/E 40, rev $2.85B vs P/E 10, rev $17.7M
Biomarin Pharmaceutical Inc (BMRN) versus First United Corporation (FUNC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Not investment advice. Open the BMRN and FUNC stock pages for the full models.
Not investment advice.